Announcements
- IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
- IGM Biosciences Announces Refocusing of Sanofi Collaboration
- IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
- IGM Biosciences Announces Third Quarter 2023 Financial Results
- IGM Biosciences to Present at Two Upcoming Investor Conferences
More ▼
Key statistics
On Monday, IGM Biosciences Inc (1K0:DUS) closed at 7.85, -16.93% below its 52-week high of 9.45, set on Apr 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.35 |
---|---|
High | 8.40 |
Low | 7.85 |
Bid | 7.95 |
Offer | 8.15 |
Previous close | 8.65 |
Average volume | 0.00 |
---|---|
Shares outstanding | 59.02m |
Free float | 22.06m |
P/E (TTM) | -- |
Market cap | 544.20m USD |
EPS (TTM) | -4.31 USD |
Data delayed at least 15 minutes, as of May 20 2024 15:30 BST.
More ▼